Skip to content

Glaukos GKOS Current ratio

Current ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
3.6×-1.4×
AbbVie logo
AbbVieABBV
0.8×0.0×
Boston Scientific logo
Boston ScientificBSX
1.9×+0.4×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.3×-0.8×
Exelixis logo
ExelixisEXEL
3.3×-0.2×

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×

Where this comes from

Calculated from Glaukos’s reported figures.

Based on the most recent quarter.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's current ratio?
Glaukos (GKOS) reported current ratio of 5.4× in Q1 2026.
How has Glaukos's current ratio changed year-over-year?
Glaukos's current ratio decreased by 16.3% year-over-year, from 6.5× to 5.4×.
What is the long-term trend for Glaukos's current ratio?
Over 5 years (2020 to 2025), Glaukos's current ratio has grown at a -13.1% compound annual growth rate (CAGR), from 9.4× to 4.7×.
What does current ratio mean?
Whether the company has enough short-term assets to cover its short-term bills.
How do you interpret current ratio?
Above 1.0 means short-term assets cover short-term liabilities. Very high values can signal idle cash or bloated inventory/receivables rather than strength — there's a healthy middle, not 'more is better'.
How does current ratio compare across companies?
Comparable within an industry. Working-capital-light businesses can operate safely below 1.0 by collecting before they pay.